The Fight for Affordable GLP1s & the Truth About Big Pharma | Dave Knapp

The Dr. Tyna Show

Dr. Tyna Moore

Alternative Health, Health & Fitness

4.9 • 1.4K Ratings

🗓️ 27 March 2025

⏱️ 89 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

On this episode I sit down with my friend Dave Knapp, an independent journalist and community leader in the world of GLP-1 receptor agonists. Living with obesity and type 2 diabetes himself, Dave has built a platform dedicated to connecting and educating people using these life-changing peptides. We break down the latest updates on the FDA’s crackdown on compounding pharmacies and what it could mean for the future of GLP-1 access. We also dive into the shady role of Pharmacy Benefit Managers (PBMs) in driving up drug prices, the realities of living with obesity, and why traditional approaches to weight loss often fall short. Dave shares insights from his personal journey, including his experiences with keto and the struggles his community has faced. Topics Discussed: What is happening with the FDA’s crackdown on compounding pharmacies and GLP-1 medications? How do Pharmacy Benefit Managers (PBMs) drive up drug prices and impact patient access? What are GLP-1 receptor agonists, and how are they changing the lives of people with obesity and type 2 diabetes? Why do traditional weight loss methods like “eat less, move more” often fail for people with metabolic disorders? What is the future of compounded GLP-1 medications, and how can patients stay informed? GLP1s Uncovered FREE 4 Part Video Series On This Episode We Cover: 00:00:00 - Introduction 00:05:17 - Dave’s background 00:11:07 - The Diabetes cycle 00:16:11 - Starting On The Pen 00:21:44 - Compound pharmacies and drug shortages 00:26:23 - Increase in compound drug use 00:29:34 – Better Accessibility 00:34:55 – PBMs & Insurance Kickbacks 00:41:31 – Copays vs. Cash Pay 00:45:29 – GLP-1 & FDA Lawsuits 00:53:14 – MAHA & Compounding Pharmacies 00:55:09 – Pharmacy Types & The Future of Compounding 00:59:47 – Confidence in Providers 01:02:13 – Bias in the MAHA Movement 01:09:19 – Lowering Medication Costs 01:11:39 – Deplatforming & Censorship 01:18:34 – “Eat Less & Move More” Show Links: GLP1s Uncovered FREE 4 Part Video Series Find A Doc Sponsored By: Nutrisense Head over to nutrisense.io/drtyna to get $125 off your program. Puori Go to Puori.com/drtyna and use code DRTYNA to get 20% off Momentous Go to livemomentous.com and try it today at 20% off with code DRTYNA, and start living on purpose. Purity Woods Go to puritywoods.com/DRTYNA or enter DRTYNA at checkout for 27% off LMNT Get your free Sample Pack with any LMNT purchase at drinkLMNT.com/drtyna Check Out Dave: Instagram https://www.onthepen.com/ Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.

Transcript

Click on a timestamp to play from that location

0:00.0	Most people in the United States are not paying $1,300 a month for OZemPEC.
0:04.5	In fact, Wigovi, which is the obesity medicine version of OZEPIC, most people that are on this are paying less than $25 a month.
0:14.1	Really?
0:15.1	Really?
0:16.1	The people who are on this are paying $25 a month.
0:18.5	Is that with insurance?
0:20.1	That's, yeah, that's with insurance, right?
0:22.2	So you have the list price at $1,300, but most people in the United States are paying
0:26.6	80% are paying $25 or less.
0:29.2	You are tuned into the Dr. Tina show with Dr. Tina Moore.
0:32.1	For more, visit Dr. Tina.com.
0:34.7	On this episode of the Dr. Tina show, I am excited for this one. I got to sit down
0:39.1	and have a great conversation with my buddy, Dave Knapp. Dave and I met through the online
0:43.4	space when I was the platform back in September for I believe talking about microdosing
0:48.0	gLP ones. He has built an entire platform called On the Pen and his his life's mission, he's become an independent
0:55.4	journalist of sorts. That's not what his background was in. But he has made it his life's
0:59.6	mission to connect people who are utilizing GLP1 agonists. He is a man living with the disease of
1:05.1	obesity, the disease of type 2 diabetes. And he knows this world well. And he's built this wonderful,
1:12.6	expansive community of like-minded people who are all utilizing these peptides with life-changing impacts. He keeps us abreast on what's
1:18.8	happening in the news. And so I brought him on today because A, I wanted you guys to get an update on
1:23.3	what's happening with the FDA versus the compounding pharmacies and those ongoing trials and what's
1:28.1	happening there because the future of compounded GLP-1s may be in jeopardy.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Dr. Tyna Moore, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Dr. Tyna Moore and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.